These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 32155980)

  • 21. Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?
    Vignesh R; Shankar EM
    EBioMedicine; 2017 Oct; 24():20-21. PubMed ID: 28865747
    [No Abstract]   [Full Text] [Related]  

  • 22. The Effect of JAK1/2 Inhibitors on HIV Reservoir Using Primary Lymphoid Cell Model of HIV Latency.
    de Armas LR; Gavegnano C; Pallikkuth S; Rinaldi S; Pan L; Battivelli E; Verdin E; Younis RT; Pahwa R; Williams SL; Schinazi RF; Pahwa S
    Front Immunol; 2021; 12():720697. PubMed ID: 34531866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purinergic signalling in host innate immune defence against intracellular pathogens.
    Coutinho-Silva R; Savio LEB
    Biochem Pharmacol; 2021 May; 187():114405. PubMed ID: 33406411
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dendritic cells potently purge latent HIV-1 beyond TCR-stimulation, activating the PI3K-Akt-mTOR pathway.
    van Montfort T; van der Sluis R; Darcis G; Beaty D; Groen K; Pasternak AO; Pollakis G; Vink M; Westerhout EM; Hamdi M; Bakker M; van der Putten B; Jurriaans S; Prins JH; Jeeninga R; Thomas AAM; Speijer D; Berkhout B
    EBioMedicine; 2019 Apr; 42():97-108. PubMed ID: 30824386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gelsolin activity controls efficient early HIV-1 infection.
    García-Expósito L; Ziglio S; Barroso-González J; de Armas-Rillo L; Valera MS; Zipeto D; Machado JD; Valenzuela-Fernández A
    Retrovirology; 2013 Apr; 10():39. PubMed ID: 23575248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.
    Kristoff J; Palma ML; Garcia-Bates TM; Shen C; Sluis-Cremer N; Gupta P; Rinaldo CR; Mailliard RB
    EBioMedicine; 2019 May; 43():295-306. PubMed ID: 30952614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cells.
    Bermejo M; López-Huertas MR; García-Pérez J; Climent N; Descours B; Ambrosioni J; Mateos E; Rodríguez-Mora S; Rus-Bercial L; Benkirane M; Miró JM; Plana M; Alcamí J; Coiras M
    Biochem Pharmacol; 2016 Apr; 106():30-45. PubMed ID: 26851491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.
    Vassena L; Giuliani E; Koppensteiner H; Bolduan S; Schindler M; Doria M
    J Virol; 2015 May; 89(10):5687-700. PubMed ID: 25822027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitors of viral entry.
    Melby T; Westby M
    Handb Exp Pharmacol; 2009; (189):177-202. PubMed ID: 19048201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 requires Arf6-mediated membrane dynamics to efficiently enter and infect T lymphocytes.
    García-Expósito L; Barroso-González J; Puigdomènech I; Machado JD; Blanco J; Valenzuela-Fernández A
    Mol Biol Cell; 2011 Apr; 22(8):1148-66. PubMed ID: 21346189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Innate immune recognition of HIV-1.
    Iwasaki A
    Immunity; 2012 Sep; 37(3):389-98. PubMed ID: 22999945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of influenza virus vaccine on the expression of human immunodeficiency virus co-receptor CCR5.
    Rucker RP; Day NK; Good RA; Kamchaisatian W; Emmanuel P; Sleasman JW; Mayeski C; Dinglasan E; Haraguchi S; Tangsinmankong N
    Ann Allergy Asthma Immunol; 2004 Sep; 93(3):272-6. PubMed ID: 15478388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multi-omics analyses reveal that HIV-1 alters CD4
    Guo H; Wang Q; Ghneim K; Wang L; Rampanelli E; Holley-Guthrie E; Cheng L; Garrido C; Margolis DM; Eller LA; Robb ML; Sekaly RP; Chen X; Su L; Ting JP
    Nat Immunol; 2021 Apr; 22(4):423-433. PubMed ID: 33767427
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid and liver X receptor agonist synergistically inhibit HIV infection in CD4+ T cells by up-regulating ABCA1-mediated cholesterol efflux.
    Jiang H; Badralmaa Y; Yang J; Lempicki R; Hazen A; Natarajan V
    Lipids Health Dis; 2012 Jul; 11():69. PubMed ID: 22676378
    [TBL] [Abstract][Full Text] [Related]  

  • 35.
    Nemeth J; Vongrad V; Metzner KJ; Strouvelle VP; Weber R; Pedrioli P; Aebersold R; Günthard HF; Collins BC
    Mol Cell Proteomics; 2017 Apr; 16(4 suppl 1):S108-S123. PubMed ID: 28223351
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a future for antiviral fusion inhibitors?
    Berkhout B; Eggink D; Sanders RW
    Curr Opin Virol; 2012 Feb; 2(1):50-9. PubMed ID: 22440966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function.
    Curriu M; Fausther-Bovendo H; Pernas M; Massanella M; Carrillo J; Cabrera C; López-Galíndez C; Clotet B; Debré P; Vieillard V; Blanco J
    PLoS One; 2012; 7(2):e30330. PubMed ID: 22312424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LIM kinase 1 modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to initiate viral infection.
    Vorster PJ; Guo J; Yoder A; Wang W; Zheng Y; Xu X; Yu D; Spear M; Wu Y
    J Biol Chem; 2011 Apr; 286(14):12554-64. PubMed ID: 21321123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.